Metraipolis › archive › dc_fa17b6942f25
Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma — Europe PMC PMID:41285809
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41285809
- DOI
- 10.1038/s41419-[numero omesso]-3
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T07:23:37.667Z
- SHA-256 of the archived text
03be48edd701fd6e5581e455a9672d4c0583ff8f8dc794847d89e596882e0fc4- Stable URL of this page
https://metraipolis.com/documento/dc_fa17b6942f25
How to cite
Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma — Europe PMC PMID:41285809 — Europe PMC (en), https://europepmc.org/article/MED/41285809 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa17b6942f25 (Metraipolis archive dc_fa17b6942f25, sha256 03be48edd701fd6e5581e455a9672d4c0583ff8f8dc794847d89e596882e0fc4)
BibTeX
@misc{dcfa17b6942f25,
title = {Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma — Europe PMC PMID:41285809},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41285809},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa17b6942f25; sha256 03be48edd701fd6e5581e455a9672d4c0583ff8f8dc794847d89e596882e0fc4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41285809. Agents can read the archived copy with the MCP tool read_document.